HETERO
Pioneering Advanced Medicine.
High-quality products with cutting-edge technology.
Elixir Pharma is proud to announce a strategic joint venture with Hetero Pharma, a global leader in generic medicines and pharmaceutical innovation. This partnership marks a significant milestone in our journey to advance healthcare solutions in Egypt. By combining Hetero’s expertise in cutting-edge research and global manufacturing capabilities with Elixir Pharma’s deep understanding of the local market, we aim to deliver high-quality, affordable medicines that meet the diverse needs of patients across the region. Together, we are committed to improving access to life-saving therapies and fostering a healthier future for our communities.
Headquartered in India, Hetero is a prominent pharmaceutical company well-known globally for its contributions to generic medicines, APIs (Active Pharmaceutical Ingredients), and biotechnology products.
Focus on Generic Medicines
-Hetero is a major supplier of affordable generic drugs, especially for life-saving medications.
-They are well-regarded for producing antiretroviral drugs for HIV treatment and have contributed significantly to global healthcare programs.
R&D and Manufacturing
-They have a strong emphasis on research and development, especially in developing cost-effective solutions for complex molecules.
-The company operates numerous state-of-the-art manufacturing facilities worldwide, adhering to global standards like USFDA, WHO-GMP, and EU regulations.
Global Reach
-Hetero exports its products to over 145 countries, serving both developed and developing markets.
-Their products include formulations, APIs, and biologics.
Notable Contributions
Hetero gained significant attention during the COVID-19 pandemic for producing generic versions of Remdesivir and other COVID-19 treatments. The company has played a role in improving accessibility to medications for diseases like cancer, diabetes, and infectious diseases.